Predict your next investment

Corporation
HEALTHCARE | Medical Facilities & Services
quintiles.com

See what CB Insights has to offer

Founded Year

1990

Stage

Merger | Merged

Valuation

$0000 

About Quintiles Transnational

Quintiles Transnational (NYSE:Q) is a provider of biopharmaceutical development services and commercial outsourcing services. The company uses the breadth and depth of its service offerings, global footprint, and therapeutic, scientific, and analytics expertise to help biopharmaceutical customers, as well as other healthcare customers, navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes.

Quintiles Transnational Headquarter Location

4820 Emperor Blvd

Durham, North Carolina, 27703,

United States

919-998-2000

Latest Quintiles Transnational News

Pharmacovigilance Market is Expected to Witness Rapid Growth by 2031 | PRA Health Sciences Inc., Quintiles Transnational Holdings Inc., Sanofi SA, Synowledge LLC and Wipro Ltd. among Others

May 6, 2021

| PRA Health Sciences Inc., Quintiles Transnational Holdings Inc., Sanofi SA, Synowledge LLC and Wipro Ltd. among Others A recent market study published by FMI on the pharmacovigilance market includes global industry analysis for 2016-2020 & opportunity assessment for 2021-2031, and delivers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters of the pharmacovigilance market , growth prospects of the market are obtained with maximum precision. Pharmacovigilance Market: Taxonomy Report Chapters Chapter 01 – Introduction The report begins with a detailed description of the market, followed by a detailed research methodology, providing insights on the primary as well as secondary sources referred to during the course of the study. Furthermore, it also provides an overview of the market’s key segments. Chapter 02 – Executive Summary This section provides an executive summary of the pharmacovigilance market, which includes a summary of key findings and statistics of the market. It also includes the demand-side & supply-side trends about the pharmacovigilance market. Chapter 03 – Pharmacovigilance Market Dynamics This chapter begins by providing a detailed taxonomy in the form of segments. This chapter explains key macro-economic factors that are expected to influence the growth of the pharmacovigilance market over the forecast period. Along with the macroeconomic factors, this section also highlights the value chain and forecast factors for the pharmacovigilance market. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided. Chapter 04 – Global Pharmacovigilance Market Analysis by Phase of Drug Development Based on phase of drug development, the pharmacovigilance market is segmented into preclinical studies, phase I, phase II, phase III and phase IV. In this chapter, readers can find information about the key trends and developments in the pharmacovigilance market and market attractiveness analysis based on phase of drug development. Chapter 05 – Global Pharmacovigilance Market Analysis by Type of Methods Based on type of methods, the pharmacovigilance market is segmented into spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event reporting and EHR mining. In this chapter, readers can find information about the key trends and developments in the pharmacovigilance market and market attractiveness analysis based on type of methods. Chapter 06 – Global Pharmacovigilance Market Analysis by Service Type Provider Based on service type provider, the pharmacovigilance market is segmented into in-house pharmacovigilance and contract outsourcing. In this chapter, readers can find information about the key trends and developments in the pharmacovigilance market and market attractiveness analysis based on service type provider. Chapter 07 – Global Pharmacovigilance Market Analysis 2016-2020 & Opportunity Assessment 2021-2031, by Geography This chapter explains how the pharmacovigilance market will grow across several geographic regions such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. Chapter 08 – North America Pharmacovigilance Market Analysis 2016-2020 & Opportunity Assessment 2021-2031 This chapter includes a detailed analysis of the growth of the North America pharmacovigilance market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on end use and countries in North America. Chapter 09 – Latin America Pharmacovigilance Market Analysis 2016-2020 & Opportunity Assessment 2021-2031 This chapter provides the growth scenario of the pharmacovigilance market in Latin American countries such as Brazil, Mexico and the Rest of Latin America. Along with this, an assessment of the market across target segments has been provided. Chapter 10 – Europe Pharmacovigilance Market Analysis 2016-2020 & Opportunity Assessment 2021-2031 Important growth prospects of the pharmacovigilance market based on its end use in several countries such as Germany, U.K., France, Spain, Italy, Russia and Rest of Europe are included in this chapter. Chapter 11 – Asia Pacific Pharmacovigilance Market Analysis 2016-2020 & Opportunity Assessment 2021-2031 Important growth prospects of the pharmacovigilance market based on its end use in several countries such as China, India, ASEAN, Japan and Rest of Asia-Pacific are included in this chapter. Chapter 12 – Middle East & Africa Pharmacovigilance Market Analysis 2016-2020 & Opportunity Assessment 2021-2031 This chapter highlights the growth of the pharmacovigilance market in Middle East & Africa by focusing on GCC countries, South Africa and Rest of MEA. This section also helps readers understand the key factors that are responsible for the growth of the pharmacovigilance market in Middle East and Africa. Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-1107 Chapter 13 – Global Pharmacovigilance Market Recommendations In this chapter, reader can glean information about recommendations concerning key market strategies implementation. This section incorporates an in-depth discussion on strategic partnerships and collaborations with CROs and life sciences BPOs, optimization of drug safety through Hub and Spoke model, developing operation activities for better outcomes and regional expansion. Chapter 14 – Global Pharmacovigilance Market Company Profiles In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the pharmacovigilance market, along with detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Accenture Plc., Bristol-Myers Squibb, Clinquest Group B.V., Cognizant Technology Solutions, Covance Inc, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc., ICON Plc, iGATE Corporation, iMED Global Corporation, inVentiv Health Inc., Novartis AG, PAREXEL International Corporation, Pfizer Inc., Pharmaceutical Product Development LLC. (PPD), PRA Health Sciences Inc., Quintiles Transnational Holdings Inc., Sanofi SA, Synowledge LLC and Wipro Ltd. among others. Explore Wide-ranging Coverage of FMI’s HealthcareLandscape Mammalian Transient Protein Expression Market  –The mammalian transient protein expression market has reflected steady growthon the back of growing demand from the biomedicine sector. Efforts into vaccinedevelopment continue to create possibilities for new opportunities. In Vitro Fertilization Banking Services Market  –According to the Centers for Disease Control and Prevention (CDC), about 10% ofwomen in the United States between ages 15 to 44 years have infertility whilethe rate of male infertility is 4.5-6% in North America. Cryopreservation for In-vitro Fertilization (IVF) Market  –According to analysis by Future Market Insights (FMI), cryopreservationfor IVF market surpassed a valuation of US$ 339 million in 2019. Themarket is set to reflect an impressive 10.2% CAGR through 2030. About FMI        Future Market Insights (FMI) is a leading provider of marketintelligence and consulting services, serving clients in over 150 countries. FMI  isheadquartered in Dubai, the global financial capital, and has delivery centersin the U.S. and India. FMI’s latest  marketresearch reports  and industry analysis help businesses navigatechallenges and make critical decisions with confidence and clarity amidstbreakneck competition. Our customized and syndicated market research reportsdeliver actionable insights that drive sustainable growth. A team of expert-ledanalysts at FMI continuously tracks emerging trends and events in a broad rangeof industries to ensure that our clients prepare for the evolving needs oftheir consumers. ContactUs

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Quintiles Transnational

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Quintiles Transnational is included in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Quintiles Transnational Patents

Quintiles Transnational has filed 11 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/20/2015

3/21/2017

Pharmaceutical industry, Clinical research, Life sciences industry, Web frameworks, Pharmaceuticals policy

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/20/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

3/21/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Pharmaceutical industry, Clinical research, Life sciences industry, Web frameworks, Pharmaceuticals policy

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.